Furthermore, diminished serum MMP-3 was also presented in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treated with rituximab [22]. Here, MMP3 is linked to anti-neutrophil cytoplasmic antibody-associated vasculitis.